by rdbiomed | Nov 21, 2019 | Company Updates
Peptest – a non-invasive device for diagnosing reflux disease – has been approved by Chinese health authorities and officially launched in China. The device detects the presence of pepsin (recognised as a diagnostic biomarker for reflux) in saliva samples. Leading... 
by rdbiomed | Nov 11, 2019 | Company Updates, LPR
Peptest has been described as a ‘cost‐effective, non-invasive measurement tool’ to assist office‐based diagnosis of laryngopharangeal reflux disease (LPR) in a new research paper. The study, published in The Laryngoscope – the monthly peer-reviewed medical... 
by rdbiomed | Nov 6, 2019 | Company Updates
The Peptest team headed to the Czech Republic in October to take part in the second annual ‘Peptest Day’ hosted by Imedex. Imedex, our exclusive distributor for the Czech Republic and Slovakia, organised the knowledge-sharing workshop to coincide with the Pneumology... 
by rdbiomed | Sep 9, 2019 | Company Updates
The Peptest team has headed to China this week to finalise plans for the official launch of our reflux diagnostic device in the world’s most populous country. In an exciting development for Peptest, we’re thrilled to reveal that following years of intensive research,... 
by rdbiomed | Sep 4, 2019 | Company Updates
We are delighted to introduce our new step-by-step video guide to using Peptest in the comfort of your own home. Peptest is an innovative diagnostic test to help identify reflux non-invasively. We measure the presence of stomach enzyme pepsin in your saliva samples.... 
by rdbiomed | Aug 19, 2019 | Company Updates
A large-scale, multicentre study that validates the effectiveness of using Peptest to diagnose patients with gastroesophageal reflux in China has been published in the Journal of Digestive Diseases. Pepsin in saliva has been recognised as a diagnostic biomarker in...
Recent Comments